Search research articles
Contact Us
Filters
Showing results (41-50 of 50) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 50 results.
Methods in Enzymology
|
November 15, 2011
The serpinopathies studying serpin polymerization in vivo
James A Irving, Ugo I Ekeowa, Didier Belorgey, et al.
Eclinicalmedicine
|
December 9, 2022
Multi-center evaluation of baseline neutrophil-to-lymphocyte (NLR) ratio as an independent predictor of mortality and clinical risk stratifier in idiopathic pulmonary fibrosis
Theresia A Mikolasch, Peter M George, Jagdeep Sahota, et al.
The Lancet. Respiratory Medicine
|
September 8, 2022
Safety, tolerability, and efficacy of pirfenidone in patients with rheumatoid arthritis-associated interstitial lung disease: a randomised, double-blind, placebo-controlled, phase 2 study
Joshua J Solomon, Sonye K Danoff, Felix A Woodhead, et al.
The Lancet. Respiratory Medicine
|
May 16, 2016
Multicentre evaluation of multidisciplinary team meeting agreement on diagnosis in diffuse parenchymal lung disease: a case-cohort study
Simon L F Walsh, Athol U Wells, Sujal R Desai, et al.
Gut
|
February 26, 2021
Hepatobiliary phenotypes of adults with alpha-1 antitrypsin deficiency
Malin Fromme, Carolin V Schneider, Vitor Pereira, et al.
The European Respiratory Journal
|
May 21, 2026
Genome-wide association study of Idiopathic Pulmonary Fibrosis susceptibility using clinically-curated European-ancestry datasets
Daniel Chin, Tamara Hernandez-Beeftink, Lauren Donoghue, et al.
Medrxiv : the Preprint Server for Health Sciences
|
February 20, 2025
Genome-wide association study of Idiopathic Pulmonary Fibrosis susceptibility using clinically-curated European-ancestry datasets
Daniel Chin, Tamara Hernandez-Beeftink, Lauren Donoghue, et al.
BMJ Open Respiratory Research
|
September 24, 2021
Understanding the burden of interstitial lung disease post-COVID-19: the UK Interstitial Lung Disease-Long COVID Study (UKILD-Long COVID)
Jim M Wild, Joanna C Porter, Philip L Molyneaux, et al.
Ebiomedicine
|
January 25, 2026
Residual lung abnormality following COVID-19 hospitalisation is characterised by biomarkers of epithelial injury
Iain Stewart, Joseph Jacob, Joanna C Porter, et al.
American Journal of Respiratory and Critical Care Medicine
|
December 2, 2022
Residual Lung Abnormalities after COVID-19 Hospitalization: Interim Analysis of the UKILD Post-COVID-19 Study
Iain Stewart, Joseph Jacob, Peter M George, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 50) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 50 results.
Methods in Enzymology
|
November 15, 2011
The serpinopathies studying serpin polymerization in vivo
James A Irving, Ugo I Ekeowa, Didier Belorgey, et al.
Eclinicalmedicine
|
December 9, 2022
Multi-center evaluation of baseline neutrophil-to-lymphocyte (NLR) ratio as an independent predictor of mortality and clinical risk stratifier in idiopathic pulmonary fibrosis
Theresia A Mikolasch, Peter M George, Jagdeep Sahota, et al.
The Lancet. Respiratory Medicine
|
September 8, 2022
Safety, tolerability, and efficacy of pirfenidone in patients with rheumatoid arthritis-associated interstitial lung disease: a randomised, double-blind, placebo-controlled, phase 2 study
Joshua J Solomon, Sonye K Danoff, Felix A Woodhead, et al.
The Lancet. Respiratory Medicine
|
May 16, 2016
Multicentre evaluation of multidisciplinary team meeting agreement on diagnosis in diffuse parenchymal lung disease: a case-cohort study
Simon L F Walsh, Athol U Wells, Sujal R Desai, et al.
Gut
|
February 26, 2021
Hepatobiliary phenotypes of adults with alpha-1 antitrypsin deficiency
Malin Fromme, Carolin V Schneider, Vitor Pereira, et al.
The European Respiratory Journal
|
May 21, 2026
Genome-wide association study of Idiopathic Pulmonary Fibrosis susceptibility using clinically-curated European-ancestry datasets
Daniel Chin, Tamara Hernandez-Beeftink, Lauren Donoghue, et al.
Medrxiv : the Preprint Server for Health Sciences
|
February 20, 2025
Genome-wide association study of Idiopathic Pulmonary Fibrosis susceptibility using clinically-curated European-ancestry datasets
Daniel Chin, Tamara Hernandez-Beeftink, Lauren Donoghue, et al.
BMJ Open Respiratory Research
|
September 24, 2021
Understanding the burden of interstitial lung disease post-COVID-19: the UK Interstitial Lung Disease-Long COVID Study (UKILD-Long COVID)
Jim M Wild, Joanna C Porter, Philip L Molyneaux, et al.
Ebiomedicine
|
January 25, 2026
Residual lung abnormality following COVID-19 hospitalisation is characterised by biomarkers of epithelial injury
Iain Stewart, Joseph Jacob, Joanna C Porter, et al.
American Journal of Respiratory and Critical Care Medicine
|
December 2, 2022
Residual Lung Abnormalities after COVID-19 Hospitalization: Interim Analysis of the UKILD Post-COVID-19 Study
Iain Stewart, Joseph Jacob, Peter M George, et al.
Page
of 5